Revvity Price to Free Cash Flow Ratio 2012-2026 | RVTY
Historical price to free cash flow ratio values for Revvity (RVTY) since 2012.
| Revvity Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-06-05 | 98.37 | 23.23 | |
| 2025-09-30 | 87.46 | $4.24 | 20.65 |
| 2025-06-30 | 96.44 | $4.19 | 23.01 |
| 2025-03-31 | 105.42 | $4.29 | 24.56 |
| 2024-12-31 | 111.14 | $4.41 | 25.20 |
| 2024-09-30 | 127.14 | $4.57 | 27.80 |
| 2024-06-30 | 104.29 | $3.09 | 33.78 |
| 2024-03-31 | 104.36 | $0.79 | 131.57 |
| 2023-12-31 | 108.57 | $0.08 | 1367.39 |
| 2023-09-30 | 109.88 | $-0.46 | 0.00 |
| 2023-06-30 | 117.84 | $1.21 | 97.66 |
| 2023-03-31 | 132.13 | $3.01 | 43.86 |
| 2022-12-31 | 138.95 | $4.70 | 29.57 |
| 2022-09-30 | 119.18 | $6.35 | 18.75 |
| 2022-06-30 | 140.79 | $7.53 | 18.69 |
| 2022-03-31 | 172.63 | $9.30 | 18.57 |
| 2021-12-31 | 198.87 | $11.35 | 17.52 |
| 2021-09-30 | 171.34 | $13.11 | 13.06 |
| 2021-06-30 | 152.60 | $12.43 | 12.27 |
| 2021-03-31 | 126.72 | $11.16 | 11.36 |
| 2020-12-31 | 141.68 | $7.43 | 19.07 |
| 2020-09-30 | 123.84 | $4.89 | 25.33 |
| 2020-06-30 | 96.73 | $3.99 | 24.25 |
| 2020-03-31 | 74.17 | $3.16 | 23.50 |
| 2019-12-31 | 95.60 | $2.58 | 37.05 |
| 2019-09-30 | 83.78 | $1.99 | 42.09 |
| 2019-06-30 | 94.70 | $2.18 | 43.54 |
| 2019-03-31 | 94.65 | $2.41 | 39.33 |
| 2018-12-31 | 77.09 | $2.29 | 33.61 |
| 2018-09-30 | 95.39 | $2.17 | 43.91 |
| 2018-06-30 | 71.75 | $1.61 | 44.50 |
| 2018-03-31 | 74.12 | $1.49 | 49.68 |
| 2017-12-31 | 71.51 | $2.26 | 31.65 |
| 2017-09-30 | 67.39 | $2.71 | 24.84 |
| 2017-06-30 | 66.51 | $2.68 | 24.79 |
| 2017-03-31 | 56.60 | $3.29 | 17.22 |
| 2016-12-31 | 50.77 | $3.08 | 16.48 |
| 2016-09-30 | 54.56 | $2.63 | 20.77 |
| 2016-06-30 | 50.90 | $2.70 | 18.86 |
| 2016-03-31 | 47.96 | $2.22 | 21.60 |
| 2015-12-31 | 51.87 | $2.28 | 22.70 |
| 2015-09-30 | 44.44 | $2.10 | 21.18 |
| 2015-06-30 | 50.83 | $2.11 | 24.04 |
| 2015-03-31 | 49.31 | $2.01 | 24.54 |
| 2014-12-31 | 42.10 | $2.26 | 18.63 |
| 2014-09-30 | 41.90 | $1.99 | 21.01 |
| 2014-06-30 | 44.95 | $2.32 | 19.40 |
| 2014-03-31 | 43.17 | $2.06 | 20.92 |
| 2013-12-31 | 39.44 | $1.51 | 26.05 |
| 2013-09-30 | 36.04 | $1.14 | 31.65 |
| 2013-06-30 | 30.96 | $0.39 | 78.44 |
| 2013-03-31 | 31.98 | $0.86 | 37.30 |
| 2012-12-31 | 30.11 | $0.96 | 31.51 |
| 2012-09-30 | 27.90 | $1.44 | 19.38 |
| 2012-06-30 | 24.35 | $1.72 | 14.15 |
| 2012-03-31 | 26.04 | $1.50 | 17.39 |
| 2011-12-31 | 18.77 | $1.71 | 10.97 |
| 2011-09-30 | 17.96 | $1.19 | 15.04 |
| 2011-06-30 | 25.10 | $0.90 | 27.85 |
| 2011-03-31 | 24.43 | $1.15 | 21.27 |
| 2010-12-31 | 23.95 | $1.20 | 19.95 |
| 2010-09-30 | 21.40 | $1.49 | 14.32 |
| 2010-06-30 | 19.04 | $1.72 | 11.10 |
| 2010-03-31 | 21.96 | $1.33 | 16.54 |
| 2009-12-31 | 18.85 | $1.06 | 17.84 |
| 2009-09-30 | 17.56 | $1.35 | 13.05 |
| 2009-06-30 | 15.81 | $1.22 | 12.91 |
| 2009-03-31 | 11.55 | $1.55 | 7.46 |
| 2008-12-31 | 12.51 | $1.54 | 8.14 |
| 2008-09-30 | 22.40 | $1.52 | 14.72 |
| 2008-06-30 | 24.91 | $1.48 | 16.82 |
| 2008-03-31 | 21.63 | $1.45 | 14.96 |
| 2007-12-31 | 23.15 | $1.42 | 16.32 |
| 2007-09-30 | 25.92 | $1.29 | 20.06 |
| 2007-06-30 | 23.07 | $1.32 | 17.53 |
| 2007-03-31 | 21.38 | $0.97 | 22.12 |
| 2006-12-31 | 19.56 | $0.74 | 26.32 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.039B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |